Our client, a mid-size biopharmaceutical company partnered with Inbeeo to develop a payer value story that can consider different clinical outcomes and be adapted to payers across targeted geographies.
The asset has a new MoA in the neurology area. This is an area with high unmet needs but an over-crowded market with many low-cost therapies. Still pending Phase II results, internal stakeholders needed to understand the asset’s potential value to payers for both best and worst case scenarios within different indications, and make plans for the development of market access materials that can reflect the product value across geographies.
Inbeeo suggested a multi-step approach, which included:
- Extensive secondary research to establish unmet needs and potential value drivers across scenarios
- Engagement with global and regional stakeholders to align on the product vision
- Development of a global value narrative
- Regional adaptation through a series of affiliate workshops
This allowed for an identification of the potential value of the product (and how to optimize this) across scenarios
Inbeeo produced a value story that is dynamic, flexible, and considers common and differentiated value messages across multiple clinical scenarios.
The material allowed the client to understand the product opportunities and discuss strategies that can cover all possible scenarios at global and regional level.